News | December 28, 2021
CDSCO expert committee recommends Emergency Use Authorisation to Covovax and Corbevax
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
Zeebon is the largest diagnostics services provider in North-Eastern states
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
The product is expected to be available in a week’s time
It plans to deliver over 300 million doses to the Indian government
DCGI approved the drug based on the review of clinical data
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
The company will market it under the brand name Molflu
This product will be manufactured at Lupin's Goa facility in India
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Subscribe To Our Newsletter & Stay Updated
